Does SINTILIMAB Cause Myelosuppression? 127 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 127 reports of Myelosuppression have been filed in association with SINTILIMAB. This represents 19.5% of all adverse event reports for SINTILIMAB.
127
Reports of Myelosuppression with SINTILIMAB
19.5%
of all SINTILIMAB reports
2
Deaths
63
Hospitalizations
How Dangerous Is Myelosuppression From SINTILIMAB?
Of the 127 reports, 2 (1.6%) resulted in death, 63 (49.6%) required hospitalization, and 11 (8.7%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SINTILIMAB. However, 127 reports have been filed with the FAERS database.
What Other Side Effects Does SINTILIMAB Cause?
Nausea (77)
Rash (72)
Vomiting (68)
Off label use (64)
Hypothyroidism (62)
Diarrhoea (61)
Fatigue (60)
Anaemia (59)
Pyrexia (51)
Therapy partial responder (51)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which SINTILIMAB Alternatives Have Lower Myelosuppression Risk?
SINTILIMAB vs SIPONIMOD
SINTILIMAB vs SIPULEUCEL-T
SINTILIMAB vs SIROLIMUS
SINTILIMAB vs SIRUKUMAB
SINTILIMAB vs SITAGLIPTIN